Map
Back to map
Immunai

Immunai

BiotechnologySeries B raised51-200
LinkedIn
Total raised
Series B
Stage
Series B
Hiring pace
5 roles / 90d
Team size
51-200
Founded
2019
HQ
New York

About Immunai

The company maps and decodes the immune system using single-cell biology and AI, aiming to power therapeutic discoveries and accelerate drug development. By translating complex immune data into actionable insights, it seeks to improve patie

Open roles · 5

Location

More startups in New York

Immunai | New York startup | CleraMap